|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
KEQU's Income from Cont. Operations Growth by Quarter and Year
Kewaunee Scientific's Income from Cont. Operations results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
Income from Cont. Operations Growth Y/Y▼
|
Income from Cont. Operations Growth Y/Y▼
|
KEQU Income from Cont. Operations (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
4th Quarter |
April |
4.95
|
11.18
|
1.09
|
-0.33
|
3rd Quarter |
January |
1.38
|
2.53
|
1.10
|
-1.29
|
2nd Quarter |
October |
3.02
|
2.83
|
-0.11
|
-3.08
|
1st Quarter |
July |
2.24
|
2.52
|
-0.72
|
-1.31
|
FY |
|
11.59
|
19.06
|
1.36
|
-6.01
|
KEQU Income from Cont. Operations fourth quarter 2025 Y/Y Growth Comment |
Kewaunee Scientific Corporation reported drop in Income from Cont. Operations in the fourth quarter 2025 by -55.75% to $ 4.95 millions, from the same quarter in 2024. The fall in the fourth quarter 2025 Kewaunee Scientific Corporation's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations growth of 4.84%.
Looking into fourth quarter 2025 results within Laboratory Analytical Instruments industry 2 other companies have achieved higher Income from Cont. Operations growth. While Kewaunee Scientific Corporation' s Income from Cont. Operations meltdown of -55.75% ranks overall at the positon no. 197 in the fourth quarter 2025.
|
KEQU Income from Cont. Operations ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
April |
-55.75 % |
925.69 % |
- |
- |
3rd Quarter |
January |
-45.45 % |
130 % |
- |
- |
2nd Quarter |
October |
6.71 % |
- |
- |
- |
1st Quarter |
July |
-11.11 % |
- |
- |
- |
FY |
|
-39.21 % |
1301.47 % |
- |
- |
KEQU Income from Cont. Operations (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
April |
258.48 % |
341.9 % |
-0.91 % |
- |
3rd Quarter |
January |
-54.3 % |
-10.6 % |
- |
- |
2nd Quarter |
October |
34.82 % |
12.3 % |
- |
- |
1st Quarter |
July |
-79.96 % |
131.19 % |
- |
- |
FY (Year on Year) |
|
-39.21 % |
1301.47 % |
- |
- |
Income from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
1302.28 % |
4.84 % |
-845.83 % |
(Apr 30 2024) |
|
(Jul 31 2020) |
|
Income from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
1302.28 % |
4.84 % |
-845.83 % |
(Apr 30 2024) |
|
(Jul 31 2020) |
|
Income from Cont. Operations by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Kewaunee Scientific's Q/Q Income from Cont. Operations Growth
Income from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
341.33 % |
24.92 % |
-100 % |
(Apr 30 2024) |
|
|
KEQU's IV. Quarter Q/Q Income from Cont. Operations Comment |
Kewaunee Scientific Corporation achieved in the IV. Quarter 2025 above company average sequential Income from Cont. Operations doubling of 258.48%, to $ 4.95 millions, from $1.38 millions in the third quarter.
Within Laboratory Analytical Instruments industry Kewaunee Scientific Corporation achieved highest sequential Income from Cont. Operations growth. While Kewaunee Scientific's Income from Cont. Operations growth quarter on quarter, overall rank is 107. |
|
|
Income from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
341.33 % |
24.92 % |
-100 % |
(Apr 30 2024) |
|
|
KEQU's IV. Quarter Q/Q Income from Cont. Operations Comment |
Kewaunee Scientific Corporation achieved in the IV. Quarter 2025 above company average sequential Income from Cont. Operations doubling of 258.48%, to $ 4.95 millions, from $1.38 millions in the third quarter.
Within Laboratory Analytical Instruments industry Kewaunee Scientific Corporation achieved highest sequential Income from Cont. Operations growth. While Kewaunee Scientific's Income from Cont. Operations growth quarter on quarter, overall rank is 107. |
|
Kewaunee Scientific's 12 Months Income from Cont. Operations Growth Year on Year
Income from Cont. Operations TTM Growth |
12 Months Ending (Apr 30 2025) |
12 Months Ending (Jan 31 2025) |
12 Months Ending (Oct 31 2024) |
12 Months Ending (Jul 31 2024) |
12 Months Ending (Apr 30 2024) |
Cumulative Income from Cont. Operations 12 Months Ending |
$ 11.58 |
$ 17.82 |
$ 18.97 |
$ 18.78 |
$ 19.06 |
Y / Y Income from Cont. Operations Growth (TTM) |
-39.22 % |
98.56 % |
151.63 % |
308.88 % |
1302.28 % |
Year on Year Income from Cont. Operations Growth Overall
Ranking |
# 20 |
# 34 |
# 20 |
# 22 |
# 19 |
Seqeuential Income from Cont. Operations Change (TTM) |
-34.98 % |
-6.06 % |
0.99 % |
-1.45 % |
112.41 % |
Seq. Income from Cont. Operations Growth (TTM) Overall
Ranking |
# 197 |
# 721 |
# 321 |
# 103 |
# 94 |
Cumulative Income from Cont. Operations growth Comment |
For the 12 months ended Apr 30 2025 Kewaunee Scientific reported a drop in Income from Cont. Operations by -39.22% year on year, to $12 millions, compare to the 98.56% growth at Jan 31 2025.
Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 20, from total ranking in previous quarter at 34. |
|
|
Income from Cont. Operations TTM Y/Y Growth Statistics |
High |
Average |
Low |
1302.28 % |
4.84 % |
-845.83 % |
|
|
|
Income from Cont. Operations TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 3 |
Sector |
# 24 |
S&P 500 |
# 197 |
|
Cumulative Income from Cont. Operations growth
Comment |
For the 12 months ended Apr 30 2025 Kewaunee Scientific reported a drop in Income from Cont. Operations by -39.22% year on year, to $12 millions, compare to the 98.56% growth at Jan 31 2025.
Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 20, from total ranking in previous quarter at 34. |
Income from Cont. Operations TTM Y/Y Growth Statistics |
High |
Average |
Low |
1302.28 % |
4.84 % |
-845.83 % |
|
|
|
Income from Cont. Operations TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 3 |
Sector |
# 24 |
S&P 500 |
# 197 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com